Aug 11, 2014 11:46 PM
Liberia - The supply of an experimental drug to treat the deadly Ebola virus is exhausted after the last doses were earmarked to be sent to West Africa, the company that makes ZMapp said Monday. The Liberian government said President Ellen Johnson Sirleaf made a direct appeal Friday to U.S. President Barrack Obama for the drug to treat doctors infected during an outbreak that has killed more than 1,000 people in Liberia, Sierra Leone, Guinea and Nigeria. A spokesperson for the Health and Human Services Department said U.S. authorities helped by connecting the drug maker with Liberian officials, Reuters reported. It was not clear when the drug would be delivered.